Back to search
TGCT
Clinical trial pipeline · Data from ClinicalTrials.gov
See which TGCT trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which TGCT trials you may qualify forBackground: \- Some people with cancer have solid tumors. Others have refractory leukemia. This may not go away after treatment. Researchers want to see if a d…
The primary purpose of this study is to assess the tolerability, pharmacokinetics, and efficacy of pimicotinib in Japanese participants with TGCT
This study evaluates the accuracy of blood-based biomarker testing to predict the presence of active testicular cancer.
Testicular germ cell tumor (TGCT) is the most common malignancy in men between 15 and 40 years. Although TCGT survivors have a good survival prognosis, they suf…
This is an open-label phase 1 study to determine the safety and tolebility of oral ABSK021 in patients with advanced solid tumor as well as the Recommended Phas…
The primary purpose of this study is to determine whether the investigational drug XmAb541 is safe and well tolerated, and to determine an optimal and safe dose…
Background: People with a family history of testicular cancer may be at increased risk for the disease. Genetic and clinical studies of patients with testicul…
This is a multicenter Phase 3 clinical study, which aims to evaluate the effectiveness of an investigational drug called vimseltinib for the treatment of tenosy…
This phase 2, multicenter, two-part, open-label, single-arm study will be conducted in Japan and will evaluate the safety, tolerability, pharmacokinetics (PK),…